SIRT3 and metabolic dysfunction-associated steatotic liver disease: In order to clarify whether the anti-NAFLD of CD38 deficiency was related to the intracellular NAD+ decline, we examined the effects of Sirt1 and Sirt3 specific inhibitors on OA-induced lipid accumulation in primary hepatocytes from CD38-/- mice.